Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_assertion type Assertion NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_head.
- NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_assertion description "[Thus, the use of synthetic inhibitors of miR-221 may prove to be a promising approach to liver cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_provenance.
- NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_assertion evidence source_evidence_literature NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_provenance.
- NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_assertion SIO_000772 20018759 NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_provenance.
- NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_assertion wasDerivedFrom befree-2016 NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_provenance.
- NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_assertion wasGeneratedBy ECO_0000203 NP782182.RAFTNA-uSGW5wFjjq3oE_8w16S5SLqswwbu0Mcy17WVhM130_provenance.